Y90-radioembolization via variant hepatic arteries: Is there a relevant risk for non-target embolization?

经变异肝动脉进行 Y90 放射性栓塞治疗:是否存在非靶向栓塞的相关风险?

阅读:1

Abstract

BACKGROUND: The hepatic arterial anatomy is highly variable, with the two most common variants being a replaced right hepatic artery (RHA) originating from the superior mesenteric artery (SMA) and a left hepatic artery (LHA) originating from the left gastric artery (LGA). These anatomical variants could potentially increase the risk for non-target embolization during Y90-Radioembolization due to the close proximity between hepatic and enteric vessel branches. AIM: To evaluate the safety of Yttrium-90 radioembolization ((90)Y-RE) with resin microspheres in patients with a variant hepatic arterial anatomy. METHODS: In this retrospective single-center observational study, 11 patients who underwent RE with (90)Y-resin microspheres via a LHA originating from the LGA, and 13 patients via a RHA originating from the SMA were included. Patient and treatment data were reviewed regarding clinical and imaging evidence of non-target embolization of (90)Y-resin microspheres to the GI tract. Positioning of the tip of the microcatheter in relationship to the last hepatoenteric side branch was retrospectively analyzed using angiographic images, cone-beam CT and pre-interventional CT-angiograms. RESULTS: None of the 24 patients developed clinical symptoms indicating a potential non-target embolization to the GI tract within the first month after (90)Y-RE. On the postinterventional (90)Y-bremsstrahlung images and/or (90)Y-positron emission tomographies, no evidence of extrahepatic (90)Y-activity in the GI tract was noted in any of the patients. The mean distance between the tip of the microcatheter and the last enteric side branch during delivery of the (90)Y microspheres was 3.2 cm (range: 1.9-5 cm) in patients with an aberrant LHA originating from a LGA. This was substantially shorter than the mean distance of 5.2 cm (range: 2.9-7.7 cm) in patients with an aberrant right hepatic originating from the SMA. CONCLUSION: (90)Y-RE via aberrant hepatic arteries appears to be safe; at least with positioning of the microcatheter tip no less than 1.9 cm distal to the last hepatoenteric side branch vessel.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。